Objective: The DSM-5 includes severity specifiers (i.e., mild, moderate, severe, extreme) for anorexia nervosa (AN), bulimia nervosa (BN), and binge-eating disorder (BED), which are determined by weight status (AN) and frequencies of binge-eating episodes (BED) or inappropriate compensatory behaviors (BN). Given limited data regarding the validity of eating disorder (ED) severity specifiers, this study examined the concurrent and predictive validity of severity specifiers in AN, BN, and BED. 
| I N T R O D U C T I O N
The publication of the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (American Psychiatric Association, 2013) introduced severity specifiers for anorexia nervosa (AN), bulimia nervosa (BN), and binge-eating disorder (BED). For AN, severity is determined by weight status: mild (BMI 17), moderate , severe , and extreme (BMI < 15). For BN, severity is based on the average frequency of inappropriate compensatory behaviors (i.e., selfinduced vomiting, laxative use, diuretic use, excessive exercise): mild (1-3 episodes per week), moderate (4-7 episodes per week), severe (8-13 episodes per week), and extreme (14 episodes per week). BED severity is determined by the average frequency of binge-eating episodes (i.e., consumption of an objectively large amount of food accompanied by a sense of loss of control over eating): mild (1-3 episodes per week), moderate (4-7 episodes per week), severe (8-13 episodes per week), and extreme (14 episodes per week). However, limited research has assessed the validity of the newly introduced DSM-5 severity specifiers across ED diagnoses.
With respect to AN, two studies found no differences between DSM-5 severity groups in ED psychopathology (Machado, Grilo, & Crosby, 2016; Sysko et al., 2016) . While one study found DSM-5
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wileyonlinelibrary.com/journal/eat Inventory (STAI; Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983) , and the Eating Disorder Quality of Life Scale (EDQOL; Engel et al., 2006) . BN participants were identified from a study that assessed the efficacy of cognitive behavioral therapy (CBT); see Mitchell et al. (2008) . Measures included the EDE, the BDI, and the Medical Outcomes Study Health Status Survey Physical Health Component score (SF-36 PHC; Ware, Kosinski, & Keller, 1994) ; the SF-36 PHC score was standardized to a T-score with a mean of 50 and an SD of 10.
Participants with BED were drawn from a study that assessed the efficacy of CBT (Peterson et al., 2009) . Measures included the EDE, the Inventory of Depressive Symptomatology (IDS; Rush, Gullion, Basco, Jarrett, & Trivedi, 1996) , the Impact of Weight on Quality of Life-Lite Questionnaire (IWQOL-Lite; Kolotkin, Crosby, Kosloski, & Williams, 2001) , and the SF-36 PHC.
| Statistical analyses
In each sample, EDE responses were recoded based on the DSM-5 algorithm (Fairburn, Cooper, & O'Connor, 2014) GLM included severity grouping as a predictor; GLMs assessing end of treatment global scores and behavioral frequencies included baseline levels of outcome variables as covariates. Negative binomial distributions were specified for count data (i.e., behavioral frequencies); binary logistic models were used for dichotomous data (i.e., abstinence). As not all participants completed all assessments, each analysis was based on available data, treating incomplete data as missing.
| R E S U L T S 3.1 | Demographics
The AN sample (n 5 109) comprised four DSM-5-based severity groups: mild (n 5 70, 64.2%), moderate (n 5 26, 23.9%), severe (n 5 9, 88.5%). Age and BMI across diagnoses are shown in Table 1 . Across samples, there were no significant differences between severity groups in age; BN and BED samples had no differences in BMI between severity groups.
| Clinical characteristics
Descriptive statistics and GLM results are shown in Table 1 . Among those with AN, the mild group evidenced significantly higher EDE global scores compared to the moderate and severe groups. In the BN sample, the extreme, severe, and moderate groups reported more end of treatment OBE and compensatory behaviors and were less likely to evidence abstinence from these behaviors compared to the mild group at end of treatment; additionally, the extreme group reported more frequent end of treatment compensatory behaviors than the moderate group. In the BED sample, the mild, moderate, and severe groups reported higher end of treatment EDE global scores than the extreme group. There were no other significant effects.
| DISCUSSION
This study examined the validity of DSM-5 severity specifiers in AN, BN, and BED. In the AN and BED samples, most participants were classified as mild or moderate in severity, whereas there was a more equal distribution across severity groups in the BN sample. In general, results samples, there were no associations between severity groups and ED psychopathology. These findings could suggest that other domains may be more accurate markers of severity, as suggested previously (Grilo et al., 2015b,c; Hartmann, Zeeck, & van, 2009; Sullivan, Bulik, Carter, & Joyce, 1996) . It is also possible that the DSM-5 severity specifiers perform better with other variables that were not assessed in this study (e.g., neurocognitive or biological domains) but which would be useful to examine in future studies.
Interestingly, a reversed effect was observed with AN, in that higher BMI (i.e., low severity) was associated with greater ED psychopathology. One possible explanation is that individuals with AN who have higher BMI experience greater concerns about weight and shape, which are core factors of the measure (EDE) that assessed ED psychopathology. Thus, ED psychopathology may be more elevated on this measure among the "less severe" AN group due to cognitive features related to body image. Alternatively, individuals low in weight (i.e., higher severity) may have been more likely to minimize symptom severity.
Regarding predictive validity, the mild BN group evidenced lower OBE and compensatory frequencies and was more likely to be abstinent from such behavior compared to other groups after a course of structured treatment. Thus, there is some support for DSM-5 severity specifiers predicting behavioral outcomes in BN, though this finding was based on a small sample size. Given the lack of differences in end of treatment EDE global scores in BN, it may be that differences in end of treatment OBEs and compensatory behaviors were related to correspondence with baseline differences in compensatory behaviors that defined severity groups. However, the end of treatment behavioral frequency findings took into account baseline frequencies and thus reflected a true change in behaviors, which would not be simply explained by baseline levels. Additionally, in BED sample, the extreme group evidenced lower end of treatment EDE global scores compared to other groups. While greater distress experienced by the extreme severity group may have motivated greater reductions in overall ED symptoms, reflected by EDE global scores, we interpret these results cautiously due to the small sample size and potential of regression to the mean.
It is important to note the limitations of this study, which relied on pre-existing samples of convenience that were limited to adults and predominantly Caucasian women. Thus, it is not clear to what extent these findings are generalizable to other demographic groups. The sample sizes in some of the severity groups were small, and thus there may not have been sufficient statistical power to detect meaningful differences with these groups. In the BN sample, we were not able to include excessive exercise and fasting as inappropriate compensatory behaviors, and applying a more narrow definition of inappropriate compensatory behaviors could have resulted in a smaller number of individuals categorized as severe and extreme in severity.
In sum, the present findings do not provide strong support for the concurrent or predictive validity of DSM-5 severity specifiers for EDs.
While some studies have supported the validity of these specifiers, the lack of support in this study could be related to small sample sizes of some severity groups, and differences in measures used in this study.
Nevertheless, results highlight the need for continued study, and the investigation of additional domains that have not been examined comprehensively in the literature. For instance, limited data exist regarding predictive validity of severity specifiers, and extant evidence has been inconclusive (Mustelin et al., 2016; Smink, van Hoeken, Oldehinkel, & Hoek, 2014) . It is yet unclear whether the frequency of a single symptom or weight status alone are sufficient indices by which to characterize ED severity, as severity dimensions based on cognitive, affective, social, and biological domains may also yield clinically useful information (Grilo et al., 2008; Keel, Crosby, Hildebrandt, Haedt-Matt, & Gravener, 2013) . It may be worth considering a multifaceted approach to characterize illness severity, and notably, the DSM-5 does not preclude the importance of other factors in determining severity (American Psychiatric Association, 2013; pp. 339, 345, 350) . Future study of relevant domains across diagnoses could improve the utility and prognostic value of severity specifiers.
